Trial Profile
A multicenter phase I study Glutadon patients with metastatic colorectal cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jul 2011
Price :
$35
*
At a glance
- Drugs PEG-glutaminase/diazo-oxo-L-norleucine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 11 Jul 2011 New trial record